InVivo closes out dismal week with big loss

|About: InVivo Therapeutics Holding... (NVIV)|By:, SA News Editor

Make no mistake, it was not a good week for shares of InVivo Therapeutics (NVIV.OB) which fell 18% on the day.

The shares are off some 66% from Monday's intraday high.

"The FDA’s increasing caution over biological grafts has been evident for a while, but seems to have caught NVIV investors by surprise," SA contributor EP Vantage said, in an article published Thursday afternoon.

Previously: NVIV plunges on update to clinical plan